ArticleNeuro-oncology practice2025

Phase II randomized glioma study to evaluate efficacy and satisfaction of rolapitant plus ondansetron in preventing chemoradiation-induced nausea and vomiting.

Mary Lou Affronti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.